ANGLE plc (ANPCF)
USD 0.31
(92.55%)
USD 0.31
(92.55%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -408 Thousand GBP | -1930.18% |
| 2022 | 613 Thousand GBP | -13.78% |
| 2021 | 711 Thousand GBP | 19.1% |
| 2020 | 597 Thousand GBP | 188.05% |
| 2019 | -678 Thousand GBP | -229.64% |
| 2018 | 523 Thousand GBP | 13.94% |
| 2017 | 459 Thousand GBP | 22.4% |
| 2016 | 375 Thousand GBP | 47.64% |
| 2015 | 254 Thousand GBP | 106.71% |
| 2014 | -3.78 Million GBP | -572.41% |
| 2013 | 801 Thousand GBP | 234.63% |
| 2012 | -594.97 Thousand GBP | -142.29% |
| 2011 | 1.4 Million GBP | -41.86% |
| 2010 | 2.42 Million GBP | -1.39% |
| 2009 | 2.45 Million GBP | -51.54% |
| 2008 | 5.06 Million GBP | 30.75% |
| 2007 | 3.87 Million GBP | 14.69% |
| 2006 | 3.37 Million GBP | -17.49% |
| 2005 | 4.09 Million GBP | 0.0% |
| 2004 | 4.09 Million GBP | 15259.26% |
| 2003 | -27 Thousand GBP | 96.04% |
| 2002 | -682 Thousand GBP | 44.64% |
| 2001 | -1.23 Million GBP | 11.62% |
| 2000 | -1.39 Million GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 305.5 Thousand GBP | 153.18% |
| 2024 Q2 | 305.5 Thousand GBP | 0.0% |
| 2023 Q1 | 370.5 Thousand GBP | 155.46% |
| 2023 Q3 | -574.5 Thousand GBP | -328.73% |
| 2023 Q4 | -574.5 Thousand GBP | 0.0% |
| 2023 FY | -11.21 Million GBP | -1930.18% |
| 2023 Q2 | -134 Thousand GBP | -136.17% |
| 2022 Q4 | -668 Thousand GBP | -216.59% |
| 2022 Q2 | -726 Thousand GBP | -660.62% |
| 2022 Q1 | 129.5 Thousand GBP | 145.12% |
| 2022 FY | 613 Thousand GBP | -13.78% |
| 2022 Q3 | -211 Thousand GBP | 70.94% |
| 2021 Q1 | 109.5 Thousand GBP | 143.11% |
| 2021 Q4 | -287 Thousand GBP | -247.88% |
| 2021 Q2 | -468 Thousand GBP | -527.4% |
| 2021 FY | 711 Thousand GBP | 19.1% |
| 2021 Q3 | -82.5 Thousand GBP | 82.37% |
| 2020 Q2 | -513 Thousand GBP | -682.95% |
| 2020 Q1 | 88 Thousand GBP | 0.0% |
| 2020 FY | 597 Thousand GBP | 188.05% |
| 2020 Q3 | -44 Thousand GBP | 91.42% |
| 2020 Q4 | -254 Thousand GBP | -477.27% |
| 2019 Q1 | -88.5 Thousand GBP | 0.0% |
| 2019 FY | -678 Thousand GBP | -229.64% |
| 2019 Q2 | 144 Thousand GBP | 262.71% |
| 2018 Q3 | -408 Thousand GBP | 0.0% |
| 2018 Q1 | -190 Thousand GBP | -53.23% |
| 2018 Q4 | -88.5 Thousand GBP | 78.31% |
| 2018 FY | 523 Thousand GBP | 13.94% |
| 2017 Q2 | 67 Thousand GBP | 0.0% |
| 2017 Q4 | -124 Thousand GBP | -285.07% |
| 2017 Q3 | 67 Thousand GBP | 0.0% |
| 2017 FY | 459 Thousand GBP | 22.4% |
| 2016 Q1 | 127 Thousand GBP | 0.0% |
| 2016 Q3 | 88 Thousand GBP | 0.0% |
| 2016 Q2 | 88 Thousand GBP | -30.71% |
| 2016 FY | 375 Thousand GBP | 47.64% |
| 2015 FY | 254 Thousand GBP | 106.71% |
| 2015 Q1 | - GBP | 0.0% |
| 2015 Q2 | - GBP | 0.0% |
| 2015 Q3 | - GBP | 0.0% |
| 2015 Q4 | 127 Thousand GBP | 0.0% |
| 2014 Q1 | - GBP | -100.0% |
| 2014 Q4 | - GBP | 0.0% |
| 2014 Q3 | - GBP | 0.0% |
| 2014 FY | -3.78 Million GBP | -572.41% |
| 2014 Q2 | - GBP | 0.0% |
| 2013 Q2 | 409 Thousand GBP | 198.08% |
| 2013 Q3 | 409 Thousand GBP | 0.0% |
| 2013 FY | 801 Thousand GBP | 234.63% |
| 2013 Q1 | -417 Thousand GBP | 0.0% |
| 2013 Q4 | 658.5 Thousand GBP | 61.0% |
| 2012 Q4 | -417 Thousand GBP | -210.76% |
| 2012 FY | -594.97 Thousand GBP | -142.29% |
| 2012 Q2 | 376.5 Thousand GBP | 0.0% |
| 2012 Q3 | 376.5 Thousand GBP | 0.0% |
| 2011 FY | 1.4 Million GBP | -41.86% |
| 2010 FY | 2.42 Million GBP | -1.39% |
| 2009 FY | 2.45 Million GBP | -51.54% |
| 2008 FY | 5.06 Million GBP | 30.75% |
| 2007 FY | 3.87 Million GBP | 14.69% |
| 2006 FY | 3.37 Million GBP | -17.49% |
| 2005 FY | 4.09 Million GBP | 0.0% |
| 2004 FY | 4.09 Million GBP | 15259.26% |
| 2003 FY | -27 Thousand GBP | 96.04% |
| 2002 FY | -682 Thousand GBP | 44.64% |
| 2001 FY | -1.23 Million GBP | 11.62% |
| 2000 FY | -1.39 Million GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | -111.399% |
| Arrayit Corporation | 2.57 Million USD | 115.844% |
| Atlantic International Corp. | -154.23 Thousand USD | -164.533% |
| Biocept, Inc. | -2.58 Million USD | 84.198% |
| Bioqual, Inc. | 7.42 Million USD | 105.492% |
| CardioGenics Holdings Inc | - USD | Infinity% |
| DermTech, Inc. | 276 Thousand USD | 247.826% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.006% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 122.741% |
| iMD Companies, Inc. | -23.63 Thousand USD | -1626.107% |
| IDenta Corp. | 662.97 Thousand USD | 161.541% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 101.771% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | 625.97% |
| InVitro International | 635.98 Thousand USD | 164.152% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 106.217% |
| Many Bright Ideas Technologies Inc. | - USD | Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | 137.339% |
| NovelStem International Corp. | 12 Thousand USD | 3500.0% |
| Optigenex Inc. | -102.96 Thousand USD | -296.247% |
| PharmChem, Inc. | 3.9 Million USD | 110.45% |
| Proteome Sciences plc | 2.09 Million USD | 119.46% |
| Response Genetics, Inc | 3.94 Million USD | 110.35% |
| Rennova Health, Inc. | 6.26 Million USD | 106.509% |
| RushNet, Inc. | 1.1 Million USD | 136.936% |
| ScreenPro Security Inc. | 856.57 Thousand USD | 147.632% |
| Stella Diagnostics Inc. | - USD | Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | -1.053% |
| Todos Medical Ltd. | 4.31 Million USD | 109.466% |